Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Broder

Showing results (31-40 of 187) with videos related to

Pageof 19
Sort By:
Viruses|September 25, 2019
Cytokine Effects on the Entry of Filovirus Envelope Pseudotyped Virus-Like Particles into Primary Human MacrophagesTzanko S Stantchev, Autumn Zack-Taylor, Nicholas Mattson, et al.
Journal of Virology|March 12, 2010
Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activityJohn Pietzsch, Johannes F Scheid, Hugo Mouquet, et al.
Expert Opinion on Biological Therapy|February 17, 2009
Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra virusesPonraj Prabakaran, Zhongyu Zhu, Xiaodong Xiao, et al.
Journal of Virology|April 30, 2003
Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteinsDiana I Albu, Agnes Jones-Trower, Amy M Woron, et al.
The Journal of Infectious Diseases|August 19, 2007
Vertical transmission and fetal replication of Nipah virus in an experimentally infected catBruce A Mungall, Deborah Middleton, Gary Crameri, et al.
Expert Review of Anti-Infective Therapy|January 31, 2006
Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related virusesZhongyu Zhu, Antony S Dimitrov, Samitabh Chakraborti, et al.
Plos One|March 28, 2013
Neutralizing antibody responses in macaques induced by human immunodeficiency virus type 1 monovalent or trivalent envelope glycoproteinsGerald V Quinnan, Pengfei Zhang, Ming Dong, et al.
Virology Journal|July 20, 2005
Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoproteinKatharine N Bossart, Bruce A Mungall, Gary Crameri, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2008
Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3Kai Xu, Kanagalaghatta R Rajashankar, Yee-Peng Chan, et al.
Virology Journal|November 25, 2010
Human TOP1 residues implicated in species specificity of HIV-1 infection are required for interaction with BTBD2, and RNAi of BTBD2 in old world monkey and human cells increases permissiveness to HIV-1 infectionBharat Khurana, Lei Zhuang, Prasun K Moitra, et al.
Pageof 19

Showing results (31-40 of 187) with videos related to

Sort By:
Pageof 19
Viruses|September 25, 2019
Cytokine Effects on the Entry of Filovirus Envelope Pseudotyped Virus-Like Particles into Primary Human MacrophagesTzanko S Stantchev, Autumn Zack-Taylor, Nicholas Mattson, et al.
Journal of Virology|March 12, 2010
Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activityJohn Pietzsch, Johannes F Scheid, Hugo Mouquet, et al.
Expert Opinion on Biological Therapy|February 17, 2009
Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra virusesPonraj Prabakaran, Zhongyu Zhu, Xiaodong Xiao, et al.
Journal of Virology|April 30, 2003
Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteinsDiana I Albu, Agnes Jones-Trower, Amy M Woron, et al.
The Journal of Infectious Diseases|August 19, 2007
Vertical transmission and fetal replication of Nipah virus in an experimentally infected catBruce A Mungall, Deborah Middleton, Gary Crameri, et al.
Expert Review of Anti-Infective Therapy|January 31, 2006
Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related virusesZhongyu Zhu, Antony S Dimitrov, Samitabh Chakraborti, et al.
Plos One|March 28, 2013
Neutralizing antibody responses in macaques induced by human immunodeficiency virus type 1 monovalent or trivalent envelope glycoproteinsGerald V Quinnan, Pengfei Zhang, Ming Dong, et al.
Virology Journal|July 20, 2005
Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoproteinKatharine N Bossart, Bruce A Mungall, Gary Crameri, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2008
Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3Kai Xu, Kanagalaghatta R Rajashankar, Yee-Peng Chan, et al.
Virology Journal|November 25, 2010
Human TOP1 residues implicated in species specificity of HIV-1 infection are required for interaction with BTBD2, and RNAi of BTBD2 in old world monkey and human cells increases permissiveness to HIV-1 infectionBharat Khurana, Lei Zhuang, Prasun K Moitra, et al.
Pageof 19